Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial register facet

Trial records for AOD-9604

11 records for AOD-9604, of which 2 are published trials.

Showing 0 records on this page

Records

11 documents

Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.

RecordCompoundPhaseStatusDesignRandomisedYearCertainty
AOD-OA-PH2AOD-9604Phase 2ReportedRandomised, double-blind, placebo-controlled2015Low
AOD-OA-PH2-PKprogramme recordAOD-9604Phase 1ReportedPhase 1 ascending dose2015Very low
AOD-OA-PH2-RENAL-IMPprogramme recordAOD-9604Phase 1ReportedPhase 1 ascending dose2015Very low
AOD-OA-PH2-HEPATIC-IMPprogramme recordAOD-9604Phase 1ReportedPhase 1 ascending dose2015Very low
AOD-OA-PH2-BODY-COMPprogramme recordAOD-9604Phase 2ReportedRandomised, double-blind, placebo-controlled2015Very low
AOD-PH2B-OBESITYAOD-9604Phase 2bProgramme discontinuedRandomised, double-blind, placebo-controlled5362007Not rated
AOD-PH2B-OBESITY-QOLprogramme recordAOD-9604Phase 2bReportedRandomised, double-blind, placebo-controlled2007Very low
AOD-PH2B-OBESITY-REGIONAL-CNprogramme recordAOD-9604Phase 3ReportedRandomised, double-blind, placebo-controlled2007Very low
AOD-PH2B-OBESITY-REGIONAL-JPprogramme recordAOD-9604Phase 3ReportedRandomised, double-blind, placebo-controlled2007Very low
AOD-PH2B-OBESITY-BODY-COMPprogramme recordAOD-9604Phase 2bReportedRandomised, double-blind, placebo-controlled2007Very low
AOD-PH2B-OBESITY-DDIprogramme recordAOD-9604Phase 1ReportedRandomised crossover2007Very low
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.